IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q3 2024 Holdings

Filed 2024-11-14 | 3 holdings | $5.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tscan Therapeutics Inc(TCRX)COM89854M101$3.1M630,00060.9%
Werewolf Therapeutics Inc(HOWL)COM95075A107$1.2M589,10224.2%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$764.2K642,20414.8%